Effectiveness and safety of non-vitamin-K antagonist oral anticoagulants versus warfarin in atrial fibrillation patients with thrombocytopenia

Safety of anticoagulation in patients with atrial fibrillation and MDS/AML complicated by thrombocytopenia: An unresolved challenge: Can they be managed? A report of three cases and literature review

(2018) Jessica Caro et al.   AMERICAN JOURNAL OF HEMATOLOGY

The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation

(2018) Jan Steffel et al.   EUROPEAN HEART JOURNAL

Non-vitamin K antagonist oral anticoagulants have better efficacy and equivalent safety compared to warfarin in elderly patients with atrial fibrillation: A systematic review and meta-analysis

(2018) In-Soo Kim et al.   Journal of Cardiology

Non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and thrombocytopenia.

(2018) Agnieszka Janion-Sadowska et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Efficacy and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Asians With Nonvalvular Atrial Fibrillation

(2018) Yi‐Hsin Chan et al.   Journal of the American Heart Association

Real-World Setting Comparison of Nonvitamin-K Antagonist Oral Anticoagulants Versus Vitamin-K Antagonists for Stroke Prevention in Atrial Fibrillation

(2017) George Ntaios et al.   STROKE

Safety and efficacy of warfarin in patients with moderate thrombocytopenia

(2017) Y.F. Lai et al.   THROMBOSIS RESEARCH

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

(2016) Paulus Kirchhof et al.   EUROPEAN HEART JOURNAL

Thrombocytopaenia as a Prognostic Indicator in Heart Failure with Reduced Ejection Fraction

(2016) Mohammad Khalid Mojadidi et al.   Heart Lung and Circulation

Rivaroxaban for treatment of suspected or confirmed heparin-induced thrombocytopenia study

(2016) L. A. Linkins et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Antithrombotic treatment in elderly patients with atrial fibrillation: a practical approach

(2015) Carmen Suárez Fernández et al.   BMC Cardiovascular Disorders

Venous Thromboembolism in Patients With Thrombocytopenia: Risk Factors, Treatment, and Outcome

(2015) Jens Kristian Baelum et al.   CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS

New oral anticoagulants: their advantages and disadvantages compared with vitamin K antagonists in the prevention and treatment of patients with thromboembolic events

(2015) Agon Mekaj et al.   Therapeutics and Clinical Risk Management

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

(2014) Craig T. January et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

(2013) Christian T Ruff et al.   LANCET

Edoxaban versus Warfarin in Patients with Atrial Fibrillation

(2013) Robert P. Giugliano et al.   NEW ENGLAND JOURNAL OF MEDICINE

Oral Apixaban for the Treatment of Acute Venous Thromboembolism

(2013) Giancarlo Agnelli et al.   NEW ENGLAND JOURNAL OF MEDICINE

Immune Thrombocytopenia Patients Requiring Anticoagulation—Maneuvering Between Scylla and Charybdis

(2013) Axel Matzdorff et al.   SEMINARS IN HEMATOLOGY

Apixaban in Patients with Atrial Fibrillation

(2011) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Apixaban versus Warfarin in Patients with Atrial Fibrillation

(2011) Christopher B. Granger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

(2011) Manesh R. Patel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Thromboembolic events are not uncommon in patients with immune thrombocytopenia

(2010) Jecko Thachil et al.   BRITISH JOURNAL OF HAEMATOLOGY

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE